Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281640394> ?p ?o ?g. }
- W4281640394 endingPage "20" @default.
- W4281640394 startingPage "9" @default.
- W4281640394 abstract "Among breast cancers without human epidermal growth factor receptor 2 (HER2) amplification, overexpression, or both, a large proportion express low levels of HER2 that may be targetable. Currently available HER2-directed therapies have been ineffective in patients with these “HER2-low” cancers." @default.
- W4281640394 created "2022-06-13" @default.
- W4281640394 creator A5000432967 @default.
- W4281640394 creator A5001053105 @default.
- W4281640394 creator A5004725639 @default.
- W4281640394 creator A5004756333 @default.
- W4281640394 creator A5007089296 @default.
- W4281640394 creator A5007286394 @default.
- W4281640394 creator A5011644667 @default.
- W4281640394 creator A5012322249 @default.
- W4281640394 creator A5013654305 @default.
- W4281640394 creator A5015202957 @default.
- W4281640394 creator A5015450747 @default.
- W4281640394 creator A5016712192 @default.
- W4281640394 creator A5024282492 @default.
- W4281640394 creator A5026459010 @default.
- W4281640394 creator A5027231412 @default.
- W4281640394 creator A5030577122 @default.
- W4281640394 creator A5032293735 @default.
- W4281640394 creator A5034917686 @default.
- W4281640394 creator A5035201433 @default.
- W4281640394 creator A5038366277 @default.
- W4281640394 creator A5038422646 @default.
- W4281640394 creator A5046758725 @default.
- W4281640394 creator A5053668514 @default.
- W4281640394 creator A5054391201 @default.
- W4281640394 creator A5056870031 @default.
- W4281640394 creator A5060825420 @default.
- W4281640394 creator A5061832044 @default.
- W4281640394 creator A5062017281 @default.
- W4281640394 creator A5062458237 @default.
- W4281640394 creator A5069050806 @default.
- W4281640394 creator A5070158409 @default.
- W4281640394 creator A5071763441 @default.
- W4281640394 creator A5073796630 @default.
- W4281640394 creator A5075942978 @default.
- W4281640394 creator A5082195410 @default.
- W4281640394 creator A5088814426 @default.
- W4281640394 creator A5089513581 @default.
- W4281640394 creator A5090188675 @default.
- W4281640394 date "2022-07-07" @default.
- W4281640394 modified "2023-10-18" @default.
- W4281640394 title "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer" @default.
- W4281640394 cites W2115100262 @default.
- W4281640394 cites W2127152525 @default.
- W4281640394 cites W2132049943 @default.
- W4281640394 cites W2137545466 @default.
- W4281640394 cites W2144790402 @default.
- W4281640394 cites W2314772071 @default.
- W4281640394 cites W2387397851 @default.
- W4281640394 cites W2528767298 @default.
- W4281640394 cites W2552099557 @default.
- W4281640394 cites W2804105316 @default.
- W4281640394 cites W2806209829 @default.
- W4281640394 cites W2917113139 @default.
- W4281640394 cites W2994917610 @default.
- W4281640394 cites W2996630100 @default.
- W4281640394 cites W3005585857 @default.
- W4281640394 cites W3018222852 @default.
- W4281640394 cites W3119128530 @default.
- W4281640394 cites W3132591297 @default.
- W4281640394 cites W3156985612 @default.
- W4281640394 cites W3179021246 @default.
- W4281640394 cites W3205289224 @default.
- W4281640394 cites W4210684267 @default.
- W4281640394 cites W4211005384 @default.
- W4281640394 cites W4220923708 @default.
- W4281640394 cites W4226051140 @default.
- W4281640394 doi "https://doi.org/10.1056/nejmoa2203690" @default.
- W4281640394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35665782" @default.
- W4281640394 hasPublicationYear "2022" @default.
- W4281640394 type Work @default.
- W4281640394 citedByCount "593" @default.
- W4281640394 countsByYear W42816403942022 @default.
- W4281640394 countsByYear W42816403942023 @default.
- W4281640394 crossrefType "journal-article" @default.
- W4281640394 hasAuthorship W4281640394A5000432967 @default.
- W4281640394 hasAuthorship W4281640394A5001053105 @default.
- W4281640394 hasAuthorship W4281640394A5004725639 @default.
- W4281640394 hasAuthorship W4281640394A5004756333 @default.
- W4281640394 hasAuthorship W4281640394A5007089296 @default.
- W4281640394 hasAuthorship W4281640394A5007286394 @default.
- W4281640394 hasAuthorship W4281640394A5011644667 @default.
- W4281640394 hasAuthorship W4281640394A5012322249 @default.
- W4281640394 hasAuthorship W4281640394A5013654305 @default.
- W4281640394 hasAuthorship W4281640394A5015202957 @default.
- W4281640394 hasAuthorship W4281640394A5015450747 @default.
- W4281640394 hasAuthorship W4281640394A5016712192 @default.
- W4281640394 hasAuthorship W4281640394A5024282492 @default.
- W4281640394 hasAuthorship W4281640394A5026459010 @default.
- W4281640394 hasAuthorship W4281640394A5027231412 @default.
- W4281640394 hasAuthorship W4281640394A5030577122 @default.
- W4281640394 hasAuthorship W4281640394A5032293735 @default.
- W4281640394 hasAuthorship W4281640394A5034917686 @default.
- W4281640394 hasAuthorship W4281640394A5035201433 @default.
- W4281640394 hasAuthorship W4281640394A5038366277 @default.
- W4281640394 hasAuthorship W4281640394A5038422646 @default.
- W4281640394 hasAuthorship W4281640394A5046758725 @default.